Elevai Labs Inc. (ELAB)
NASDAQ: ELAB · Real-Time Price · USD
2.560
+0.210 (8.94%)
At close: Dec 20, 2024, 4:00 PM
2.530
-0.030 (-1.17%)
After-hours: Dec 20, 2024, 7:59 PM EST
Company Description
Elevai Labs Inc., a skincare development company, designs, manufactures, and markets skincare products in the United States.
The company offers Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions.
It serves dermatologists, plastic surgeons, medical spa owners, and physicians focused on aesthetic and therapeutic skincare.
The company was formerly known as Reactive Medical Labs Inc. and changed its name to Elevai Labs, Inc. in December 2021.
Elevai Labs Inc. was incorporated in 2020 and is based in Newport Beach, California.
Elevai Labs Inc.
| Country | United States |
| Founded | 2020 |
| IPO Date | Nov 21, 2023 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 18 |
| CEO | Graydon Bensler |
Contact Details
Address: 120 Newport Center Drive, Suite 250 Newport Beach, California 92660 United States | |
| Phone | 866-794-4940 |
| Website | elevaiskincare.com |
Stock Details
| Ticker Symbol | ELAB |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $4.00 |
| CIK Code | 0001840563 |
| ISIN Number | US28622K1043 |
| Employer ID | 85-1399981 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Graydon Bensler C.F.A. | Chief Executive Officer, Chief Financial Officer, Secretary and Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 27, 2024 | 8-K | Current Report |
| Nov 26, 2024 | 8-K | Current Report |
| Nov 26, 2024 | 8-K | Current Report |
| Nov 25, 2024 | DEFR14C | Filing |
| Nov 25, 2024 | DEFR14C | Filing |
| Nov 22, 2024 | SC TO-I/A | Filing |
| Nov 22, 2024 | 8-K | Current Report |
| Nov 21, 2024 | DEF 14C | Filing |
| Nov 21, 2024 | DEF 14C | Filing |
| Nov 14, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |